Hypothesis: Kisspeptin mediates male hypogonadism in obesity and type 2 diabetes

Neuroendocrinology

Volumn 91, Issue 4, 2010, Pages 302-307

  George, Jyothis T ^a   Millar, Robert P ^a,c   Anderson, Richard A ^a,b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Diabetes; GPR 54; Hypogonadism; KISS1; KISS1R; Kisspeptin; Metabolic syndrome; Metabolism; Obesity; Testosterone

Indexed keywords

AROMATASE INHIBITOR; ESTRADIOL; ESTROGEN; ESTRONE; GONADORELIN; GONADOTROPIN; KISSPEPTIN; LEPTIN; TESTOSTERONE; KISS1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ANDROGEN DEFICIENCY; DISEASE SEVERITY; DOWN REGULATION; ENERGY; GENE MUTATION; GONADORELIN RELEASE; GONADOTROPIN RELEASE; HUMAN; HYPERGLYCEMIA; HYPOGONADISM; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INFLAMMATION; METABOLISM; NERVE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TESTOSTERONE RELEASE; ANIMAL; COMPLICATION; MALE;

ANIMALS; DIABETES MELLITUS, TYPE 2; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOGONADISM; MALE; OBESITY; TUMOR SUPPRESSOR PROTEINS; KISSPEPTINS;

EID: 77954647851     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000299767     Document Type: Review

References (48)

1. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of obesity. Gastroenterology 2007; 132: 2087-2102.
2. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
3. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group: The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
4. Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S, Mohanty P: Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med 2008; 8: 816-828.
5. Strain GW, Zumoff B, Miller LK, et al: Effect of massive weight loss on hypothalamic-pituitary- gonadal function in obese men. J Clin Endocrinol Metab 1988; 66: 1019-1023.
6. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P: Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 5462-5468.
7. Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB: Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab 2008; 93: 3403-3410.
8. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB: Low sex hormone- binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 2006; 91: 843-850.
9. Kapoor D, Goodwin E, Channer KS, Jones TH: Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006; 154: 899-906.
10. Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, et al: Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart 2004; 90: 871-876.
11. Hill JW, Elmquist JK, Elias CF: Hypothalamic pathways linking energy balance and reproduction. Am J Physiol Endocrinol Metab 2008; 294:E827-E832.
12. Roseweir AK, Millar RP: The role of kisspeptin in the control of gonadotrophin secretion. Hum Reprod Update 2009; 15: 203-212.
13. Vermeulen A, Kaufman J, Deslypere J, Thomas G: Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab 1993; 76: 1140-1146.
14. Tripathy D, Dhindsa S, Garg R, Khaishagi A, Syed T, Dandona P: Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: a common defect? Metab Syndr Relat Disord 2003; 1: 75-80.
15. Lee J, Miele ME, Hicks DJ, et al: KiSS-1, a novel human malignant melanoma metastasis- suppressor gene. J Natl Cancer Inst 1996; 88: 1731-1737.
16. Dhillo WS, Chaudhri OB, Patterson M, et al: Kisspeptin-54 stimulates the hypothalamicpituitary gonadal axis in human males. J Clin Endocrinol Metab 2005; 90: 6609-6615.
17. Tena-Sempere M: KiSS-1 and reproduction: focus on its role in the metabolic regulation of fertility. Neuroendocrinology 2006; 83: 275-281.
18. de Roux N, Genin E, Carel J, Matsuda F, Chaussain J, Milgrom E: Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003; 100: 10972-10976.
19. Chan Y, Broder-Fingert S, Seminara SB: Reproductive functions of kisspeptin and Gpr54 across the life cycle of mice and men. Peptides 2009; 30: 42-48.
20. Seminara SB, Messager S, Chatzidaki EE, et al: The GPR54 gene as a regulator of puberty. N Engl J Med 2003; 349: 1614-1627.
21. Colledge WH: Transgenic mouse models to study Gpr54/kisspeptin physiology. Peptides 2009; 30: 34-41.
22. Oakley AE, Clifton DK, Steiner RA: Kisspeptin signaling in the brain. Endocr Rev 2009; 30: 713-743.
23. Rometo AM, Krajewski SJ, Lou Voytko M, Rance NE: Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys. J Clin Endocrinol Metab 2007; 92: 2744-2750.
24. Schneider G, Kirschner M, Berkowitz R, Ertel N: Increased estrogen production in obese men. J Clin Endocrinol Metab 1979; 48: 633-638.
25. Loves S, Ruinemans-Koerts J, de Boer H: Let rozole once a week normalizes serum testosterone in obesity-related male hypogonadism. Eur J Endocrinol 2008; 158: 741-747.
26. Herbison AE: Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr Rev 1998; 19: 302-330.
27. Smith JT, Clifton DK, Steiner RA: Regulation of the neuroendocrine reproductive axis by kisspeptin-GPR54 signaling. Reproduction 2006; 131: 623-630.
28. Navarro VM, Castellano JM, Fernández- Fernández R, et al: Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide. Endocrinology 2004; 145: 4565-4574.
29. Franceschini I, Lomet D, Cateau M, Delsol G, Tillet Y, Caraty A: Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha. Neurosci Lett 2006; 401: 225-230.
30. Smith JT, Cunningham MJ, Rissman EF, Clifton DK, Steiner RA: Regulation of Kiss1 Gene Expression in the Brain of the Female Mouse. Endocrinology 2005; 146: 3686-3692.
31. Farooqi IS, O'Rahilly S: Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009; 89: 980S-984S.
32. Isidori AM, Caprio M, Strollo F, et al: Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999; 84: 3673-3680.
33. Rasouli N, Kern PA: Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008; 93:S64-S73.
34. Finn PD, Cunningham MJ, Pau KY, Spies HG, Clifton DK, Steiner RA: The stimulatory effect of leptin on the neuroendocrine reproductive axis of the monkey. Endocrinology 1998; 139: 4652-4662.
35. Smith JT, Acohido BV, Clifton DK, Steiner RA: KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol 2006; 18: 298-303.
36. Castellano JM, Navarro VM, Fernández-Fernández R, et al: Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 2005; 146: 3917-3925.
37. Navarro VM, Fernández-Fernández R, Castellano JM, et al: Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54. J Physiol 2004; 561: 379-386.
38. Castellano JM, Navarro VM, Fernández-Fernández R, et al: Expression of hypothalamic KiSS-1 system and rescue of defective gonadotropic responses by kisspeptin in streptozotocin-induced diabetic male rats. Diabetes 2006; 55: 2602-2610.
39. Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P: Testosterone concentration in young patients with diabetes. Diabetes Care 2008; 31: 2013-2017.
40. Bruning JC, Gautam D, Burks DJ, et al: Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 289: 2122-2125.
41. Castellano JM, Roa J, Luque RM, Dieguez C, Aguilar E, Pinilla L, et al: KiSS-1/kisspeptins and the metabolic control of reproduction: physiologic roles and putative physiopathological implications. Peptides 2009; 30: 139-145.
42. Sattar N, Perry CG, Petrie JR: Type 2 diabetes as an inflammatory disorder. Br J Diabetes Vasc Dis 2003; 3: 36-41.
43. Iwasa T, Matsuzaki T, Murakami M, et al: Decreased expression of kisspeptin mediates acute immune/inflammatory stress-induced suppression of gonadotropin secretion in female rat. J Endocrinol Invest 2008; 31: 656-659.
44. Horikoshi Y, Matsumoto H, Takatsu Y, et al: Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 2003; 88: 914-919.
45. Ramachandran R, Patterson M, Murphy KG, et al: Preanalytical factors affecting RIA measurement of plasma kisspeptin. Clin Chem 2008; 54: 615-617.
46. Jayasena CN, Nijher GMK, Chaudhri OB, et al: Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab 2009; 94: 4315-4323.
47. Roseweir AK, Kauffman AS, Smith JT, et al: Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci 2009; 29: 3920-3929.
48. Castellano JM, Navarro VM, Roa J, et al: Alterations in hypothalamic KiSS-1 system in experimental diabetes: early changes and functional consequences. Endocrinology 2009; 150: 784-794.